Gsk Share Discussion Threads

[philanderer] 18/1/2022 00:18

“GlaxoSmithKline’s share price has jumped on the news as Unilever’s actions effectively fire the starting gun for a bid war for the consumer goods unit. Nestle could be interested, so too private equity.”

ADVFN market report

[spyder] 17/1/2022 17:48

—> TM
Thank you, yes you are right, I got a bit carried away with the whole bidding for the company malarkey!

[watfordhornet] 17/1/2022 15:26

Can't see this going through.Why would the large ULVR shareholders vote for this. Hopefully it will establish a floor on the GSK consumer value but be staggered if the ULVR voted it through.They certainly don't appear supportive given the share price today

[tradermichael] 17/1/2022 15:11

abdullla, equally, I shall miss the dividends which have enabled me to acquire 000's of 'free' shares over the years!

[tradermichael] 17/1/2022 15:03

Agree (at least with the Unilever part)! ......;0)

[patientcapital] 17/1/2022 15:01

I'd rather receive the two listed GSK companies in the event that the demerger is carried out as planned. We can all buy Unilever directly if we so desire which I don't having disposed of all my family holdings in 2020. The direction the Unilever management has taken with regard to fashionable ideas and notions is unappealing at this moment in time. It's management should concentrate on running better what it already has.

[tradermichael] 17/1/2022 15:01

abdullla - Probably will be different! Both mega deals, both world leaders but VOD was a 'service' industry, GSK medical and consumer product based.

But (as you well remember) my bells are ringing as well at this time and I will make money again by selling out at substantial profit before any sale (or indeed an eventual split)so as to avoid becoming the reluctant inheritor of shares in a company not of my choosing and managing a stock/s for which historical prices have little meaning.

[careful] 17/1/2022 14:49

A few more ulvr shares and a little more cash could be acceptable here.

Because of synergies consumer division could be worth more to ulvr than gsk.
Both companies shareholders could be winners here.

[abdullla] 17/1/2022 14:44

TM your old sweat heart Vodafone sold their vzw as an asset for $130 billion,after consolidations Vodafone share holders lost money on the new shares,NOW your darling GSK is going to do what Vodafone did,do you think it will be different this time???

[tradermichael] 17/1/2022 14:08

spyder - is this classed as a takeover? It is a proposed sale of partial assets

[spyder] 17/1/2022 14:00

Does anyone know at what point the Takeover Panel will intervene? ie set a deadline for any revised offer?

[tradermichael] 17/1/2022 13:19

The US market is insulated today because its Luther King Day (market is closed).

[tradermichael] 17/1/2022 13:17

I suspect that the amount on offer did not change, but that it was only the proportion of ULVR shares to cash that changed. Not happy to end up with my share of GBP8.3 billion in Unilever shares.

[alphorn] 17/1/2022 13:15

TM - my thoughts too; why only today (17 Jan) do we have the update after all this time? Something a little strange.
Some smart US attorneys will be running their slide rules over the events. The share price rise was in effect deferred until today.

If the event was deemed material today - then it was material mid December too.

[tradermichael] 17/1/2022 13:00

QP, Alp - I read that the Unilever bid was the third they'd made in December. Only details of the most recent one have been released (after at least 3 weeks). I wonder whether that will be the end of it?

[alphorn] 17/1/2022 12:11

A coffee thought - with these bids (albeit non binding) being on the table since December I wonder if any stock option awards have taken place since that date?

[quepassa] 17/1/2022 12:00

I have not read that this is the final bid from Unilever.

Having said that, it puts a firm floor to the valuation for a market spin-off.

Either way, this is excellent news for valuations and for shareholders.

ALL IMO. DYOR.
QP

[alphorn] 17/1/2022 11:45

Essential - yes, GW+SKB destroyed shareholder value. Bigger is not better if the corporate action can not be managed properly.
There are doubts re J&J and I would not underestimate the business disruption here with such a major move.

[essentialinvestor] 17/1/2022 11:21

Alp, you would remember the Glaxo Welcome/SKB merger, around the top of the tech bubble?.

Interesting the ULVR move for GSK Consumer Products also comes at arguably another
a high liquidity tide, just as then.

[alphorn] 17/1/2022 10:59

Also other options in the sector - Johnson & Johnson announced in November that it plans to spin off its consumer business into a new publicly traded company by November 2023.

[tradermichael] 17/1/2022 10:52

There was a reasonable chance that the Consumer Healthcare part of GSK would attract an offer (the split itself is well-known anyway). But this is for a third of GSK and its not as if all of GSK is involved! So, I think there will be an opportunity to buy back in at a lower price than today's 1737p high.

[medieval blacksmith] 17/1/2022 10:42

Why now? Don't understand why you would when there is a reasonable chance of an improved offer coming in and the stock is only up 3-4% on that of Friday.